December 07, 2025 a 02:46 am
LH: Dividend Analysis - Labcorp Holdings Inc.
Labcorp Holdings Inc. exhibits a moderate dividend yield at approximately 1.07%, complemented by a strong dividend history spanning 9 years. The recent dividend growth is modest but shows potential for continued steady increases. However, investors should be cautious with the company's payout ratios, especially given the large market capitalization of over $21 billion.
Overview 📊
The overview highlights Labcorp Holdings Inc.'s robust presence in the healthcare sector, offering a dividend yield of 1.07%. With a current dividend per share of $2.90, the company has maintained a solid dividend history, having avoided cuts since 1994.
| Aspect | Detail |
|---|---|
| Sector | Healthcare |
| Dividend yield | 1.07 % |
| Current dividend per share | $2.90 USD |
| Dividend history | 9 years |
| Last cut or suspension | 1994 |
Dividend History 🗣️
Labcorp's dividend history reflects stability, critical for income-focused investors. Long-term consistency in dividend payments with the last interruption decades ago underscores reliability.
| Year | Dividend Per Share (USD) |
|---|---|
| 2025 | 2.88 |
| 2024 | 2.88 |
| 2023 | 2.68 |
| 2022 | 1.86 |
| 1994 | 0.17 |
Dividend Growth 📈
Assessing dividend growth provides insights into a company's financial health and future yield potential. Labcorp's growth rates suggest a cautious approach due to modest increases in recent years.
| Time | Growth |
|---|---|
| 3 years | 1.56 % |
| 5 years | 0.76 % |
The average dividend growth is 0.76% over 5 years. This shows moderate but steady dividend growth.
Payout Ratio ⚖️
The payout ratio indicates how sustainable a company's dividend payments are. A balance between EPS and FCF-based payout ratios suggests prudence in maintaining dividend payments without undue strain on earnings or cash flow.
| Key figure | Ratio |
|---|---|
| EPS-based | 28.16 % |
| Free cash flow-based | 17.40 % |
The payout ratio of 28.16% (EPS) and 17.40% (FCF) indicates healthy risk management, though opportunities for higher dividends exist given the low ratios.
Cashflow & Capital Efficiency 💵
Analyzing cash flow and capital efficiency is crucial for understanding long-term financial health and potential reinvestment capabilities. Metrics show Labcorp’s focus on maintaining financial discipline.
The calculated metrics reveal Labcorp's capability to generate dependable cash flows and effectively reinvest funds for operational growth, emphasizing prudent capital management.
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Free Cash Flow Yield | 5.70 % | 4.42 % | 8.00 % |
| Earnings Yield | 3.88 % | 2.11 % | 6.94 % |
| CAPEX to Operating Cash Flow | 23.44 % | 34.16 % | 24.64 % |
| Stock-based Compensation to Revenue | 0.90 % | 1.06 % | 0.98 % |
| Free Cash Flow / Operating Cash Flow Ratio | 69.11 % | 65.84 % | 75.36 % |
Labcorp’s consistent cash flow generation and effective capital usage strengthen its operational stability and investment attractiveness.
Balance Sheet & Leverage Analysis 🏦
A thorough balance sheet and leverage analysis provide insights into a company's financial solidity and leverage management, emphasizing sustainability and growth potential.
Labcorp maintains a stable debt structure with robust leverage ratios, signaling sound financial management and strategic positioning for future growth.
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Debt-to-Equity | 0.90 | 0.76 | 0.62 |
| Debt-to-Assets | 0.40 | 0.36 | 0.31 |
| Debt-to-Capital | 0.47 | 0.43 | 0.38 |
| Net Debt to EBITDA | 3.18 | 4.01 | 3.03 |
| Current Ratio | 1.55 | 1.17 | 1.50 |
| Quick Ratio | 1.30 | 1.02 | 1.35 |
| Financial Leverage | 2.28 | 2.12 | 2.00 |
The ratios indicate that Labcorp efficiently utilizes debt, maintaining a prudent balance between leverage and liquidity.
Fundamental Strength & Profitability 💼
Fundamental strength and profitability analysis underline the company's ability to generate sustainable earnings and long-term value.
With competitive return and margin metrics, Labcorp showcases solid profitability, enhancing investor confidence in continued robust performance.
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Return on Equity | 9.26 % | 5.31 % | 12.67 % |
| Return on Assets | 4.06 % | 2.50 % | 6.35 % |
| Net Margin | 5.73 % | 3.44 % | 10.78 % |
| EBIT Margin | 8.98 % | 6.32 % | 11.95 % |
| EBITDA Margin | 13.92 % | 11.10 % | 16.47 % |
| Gross Margin | 27.86 % | 27.67 % | 31.26 % |
| R&D to Revenue | 0.00 % | 0.02 % | 0.00 % |
Labcorp's margins reflect operational efficiency and strategic cost management, which contribute to its competitive positioning.
Price Development 📉
Dividend Scoring System ✅
| Category | Description | Score |
|---|---|---|
| Dividend yield | Moderate Yield | |
| Dividend Stability | Consistent over 9 years | |
| Dividend growth | Slow Growth | |
| Payout ratio | Sustainable | |
| Financial stability | Strong | |
| Dividend continuity | No recent cuts/suspensions | |
| Cashflow Coverage | Healthy | |
| Balance Sheet Quality | Robust |
Total Score: 39/40
Rating ⭐️
Labcorp Holdings Inc. stands out as a stable dividend payer with a strong balance sheet and consistent payment history. While the dividend yield is modest, its sustainability and growth potential make it a reliable choice for income investors seeking long-term capital appreciation.